| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Department of Pediatrics, Hokkaido University School of Medicine, Sapporo, Japan;
Department of Human Gene Therapy, Hokkaido University School of Medicine, Sapporo, Japan;
National Institutes of Health, National Cancer Institute, Metabolism Branch, Bethesda, MD 20892;
§
Department of Pediatrics, Nagasaki University School of Medicine, Nagasaki, Japan
The Wiskott-Aldrich syndrome (WAS) is caused by defects in the WAS protein (WASP) gene on the X chromosome. Previous study disclosed that flow cytometric analysis of intracellular WASP expression (FCM-WASP analysis) in lymphocytes was useful for the diagnosis of WAS patients. Lymphocytes from all WAS patients showed WASPdim instead of WASPbright. Here we report that FCM-WASP analysis in monocytes could be a useful tool for the WAS carrier diagnosis. Monocytes from all nine WAS carriers showed varied population of WASPdim together with WASPbright. None of control individuals possessed the WASPdim population. In contrast, lymphocytes from all the carriers except two lacked the WASPdim population. The difference of the WASPdim population in monocytes and lymphocytes observed in WAS carriers suggests that WASP plays a more critical role in the development of lymphocytes than in that of monocytes. The present studies suggest that a skewed X-chromosomal inactivation pattern observed in WAS carrier peripheral blood cells is not fixed at the hemopoietic stem cell level but progresses after the lineage commitment.
This article has been cited by other articles:
|
|
 |
|
  C. Lacout, E. Haddad, S. Sabri, F. Svinarchouk, L. Garcon, C. Capron, A. Foudi, R. Mzali, S. B. Snapper, F. Louache, et al. A defect in hematopoietic stem cell migration explains the nonrandom X-chromosome inactivation in carriers of Wiskott-Aldrich syndrome Blood, August 15, 2003; 102(4): 1282 - 1289. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. I. Lutskiy, Y. Sasahara, D. M. Kenney, F. S. Rosen, and E. Remold-O'Donnell Wiskott-Aldrich syndrome in a female Blood, September 26, 2002; 100(8): 2763 - 2768. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Yamaguchi, T. Ariga, M. Yamada, D. L. Nelson, R. Kobayashi, C. Kobayashi, Y. Noguchi, Y. Ito, K. Katamura, Y. Nagatoshi, et al. Mixed chimera status of 12 patients with Wiskott-Aldrich syndrome (WAS) after hematopoietic stem cell transplantation: evaluation by flow cytometric analysis of intracellular WAS protein expression Blood, July 30, 2002; 100(4): 1208 - 1214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Wada, S. H. Schurman, M. Otsu, E. K. Garabedian, H. D. Ochs, D. L. Nelson, and F. Candotti Somatic mosaicism in Wiskott-Aldrich syndrome suggests in vivo reversion by a DNA slippage mechanism PNAS, July 5, 2001; (2001) 151260498. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ariga, T. Kondoh, K. Yamaguchi, M. Yamada, S. Sasaki, D. L. Nelson, H. Ikeda, K. Kobayashi, H. Moriuchi, and Y. Sakiyama Spontaneous In Vivo Reversion of an Inherited Mutation in the Wiskott-Aldrich Syndrome J. Immunol., April 15, 2001; 166(8): 5245 - 5249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Wada, S. H. Schurman, M. Otsu, E. K. Garabedian, H. D. Ochs, D. L. Nelson, and F. Candotti Somatic mosaicism in Wiskott-Aldrich syndrome suggests in vivo reversion by a DNA slippage mechanism PNAS, July 17, 2001; 98(15): 8697 - 8702. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
